top of page
Red Fabric_edited.jpg

International Faculty

Prof. Martin Van Den Bent

Eramus MC Cancer Institute

Netherlands

Driving practice-changing clinical trials in glioma for over three decades.

Key architect of international neuro-oncology guidelines. Past President of EANO and leader within EORTC and RANO. Transforming evidence into everyday clinical care.Architect of modern neuro-oncology: trials, guidelines, and global collaboration.

Dr. Rupesh Kotecha

Miami Cancer Institute

USA

International leader in precision radiosurgery and advanced CNS radiation therapy

Internationally recognized expert in stereotactic radiosurgery and CNS tumors. Director of CNS Metastasis Program and Chief of Radiosurgery. CNS co-chair, Proton Collaborative Group; NCI Glioblastoma CIG coordinator. Driving innovation from trials to treatment.

Dr. Santosh Kesari

The Lundquist Institute

USA

Pioneering translational neuro- oncology from cancer stem cells to patient care.

Internationally recognized neuro-oncologist and neurologist. Chair of Translational Neurosciences and Director of Neuro-oncology. A leading voice in brain tumor biology and therapeutics. Advancing science from bench to bedside.

Dr. Deepa Sampath

MD Anderson Cancer Institute

USA

Targeting epigenetic drivers of cancer resistance from leukemias to glioblastoma.

Decoding epigenetic and transcriptional drivers of cancer resistance. Leader in targeting BRD4, HDACs, PRMT5, and mutant p53 across malignancies. Translational research spanning CLL, AML, and glioblastoma. Turning resistance biology into therapeutic opportunity.

Prof.Dr. Shanop Shuangshoti

Bumrungrand International Hospital

Thailand

A pioneer in neuropathology advancing the diagnosis and understanding of CNS tumors.

A leading authority in neuropathology and CNS tumor diagnostics. Professor of Pathology at Chulalongkorn University, Bangkok.Author of seminal work spanning brain tumors, molecular genetics, and neuro-oncology. Shaping neuropathology practice through scholarship, teaching, and leadership.

Dr. Vinay Puduvalli

MD Anderson Cancer Institute

USA

A leading authority in the clinical and translational management of malignant gliomas, integrating epigenetics and apoptosis-based approaches into novel therapies.

He is a Professor, Chair, and Co-Director of the Brain Tumor Center in the Department of Neuro-Oncology at The University of Texas MD Anderson Cancer Center, Houston. A leading expert in malignant gliomas, his work spans patient care, investigator-initiated clinical trials, and translational research focused on epigenetic and apoptosis-based therapies. He is a recipient of the NCI Triennial Audit Award and has led multiple landmark clinical trials of epigenetic therapies in aggressive brain tumors.

Dr. Areeba Patel

Heidelberg Epignostix GmbH

Germany

Research scientist at the German Cancer Research Center, working across paediatric neuro-oncology, neuropathology, and AI in oncology

She is a Doctoral Researcher in Bioinformatics at University Hospital Heidelberg and the German Cancer Research Center (DKFZ), with research interests in computational neuropathology and molecular cancer genetics. She is a recipient of the British Council India 70th Anniversary Scholarship for Women in STEM.

Dr. Ashwatha Narayana

Northwell Westchester Hospital and Phelps Hospital

USA

Internationally recognised radiation a oncologist and neuro-oncology leader

He practices at the Northwell Health Cancer Institute and serves on the National Comprehensive Cancer Network Central Nervous System Panel. He has authored over 80 peer-reviewed publications, delivered 120+ invited lectures globally, and has been instrumental in establishing Gamma Knife, stereotactic radiosurgery, and brachytherapy programs across the US, India, Nepal, and Russia.

Copyright © 2026 - All Rights Reserved
ISNOCON 2026

Conference

Managed by

Jaws Logo.png
bottom of page